Filing Details

Accession Number:
0001209191-23-056768
Form Type:
4
Zero Holdings:
No
Publication Time:
2023-11-28 16:10:01
Reporting Period:
2023-11-27
Accepted Time:
2023-11-28 16:10:01
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1845459 Nkgen Biotech Inc. NKGN Biological Products, (No Disgnostic Substances) (2836) 000000000
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1991119 Y. Paul Song Nkgen Biotech, Inc.
3001 Daimler Street
Santa Ana CA 92705
Chief Executive Officer Yes Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2023-11-27 103 $2.91 170,561 No 4 P Direct
Common Stock Acquisiton 2023-11-27 140 $2.85 170,701 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
No 4 P Direct